Differential somatic Ca2+ channel profile in midbrain dopaminergic neurons

Journal of Neuroscience

Volumn 36, Issue 27, 2016, Pages 7234-7245

  Philippart, Fabian ^a   Destreel, Geoffrey ^a   Merino Sepúlveda, Paulina ^b   Henny, Pablo ^b   Engel, Dominique ^a   Seutin, Vincent ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Action potential clamp; Dopaminergic neurons; Neurodegeneration; Nonstationary fluctuation analysis; Nucleated patches; Voltage dependent calcium channels

Indexed keywords

CALCIUM CHANNEL L TYPE; CALCIUM; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; TYROSINE 3 MONOOXYGENASE;

ADULT; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FIRING RATE; HYPERPOLARIZATION; IMMUNOCYTOCHEMISTRY; MALE; MEMBRANE POTENTIAL; NERVE CELL DEGENERATION; NERVE POTENTIAL; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NONHUMAN; PATCH CLAMP TECHNIQUE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA PARS COMPACTA; VENTRAL TEGMENTUM; ACTION POTENTIAL; ANIMAL; BIOPHYSICS; CLASSIFICATION; CYTOLOGY; DRUG EFFECTS; ELECTROSTIMULATION; FEMALE; IN VITRO STUDY; MESENCEPHALON; METABOLISM; NEWBORN; PHYSIOLOGY; WISTAR RAT;

ACTION POTENTIALS; ANIMALS; ANIMALS, NEWBORN; BIOPHYSICS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; DOPAMINERGIC NEURONS; ELECTRIC STIMULATION; FEMALE; IN VITRO TECHNIQUES; MALE; MESENCEPHALON; PATCH-CLAMP TECHNIQUES; RATS; RATS, WISTAR; TYROSINE 3-MONOOXYGENASE;

EID: 84977560899     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0459-16.2016     Document Type: Article

References (60)

1. 2+ conductances in layer 5 neocortical pyramidal neurons from rats. PLoS One 4:e4941. CrossRef
2. Almog M, Korngreen A (2014) A quantitative description of dendritic conductances and its application to dendritic excitation in layer 5 pyramidal neurons. J Neurosci 34:182-196. CrossRef Medline
3. 2+ regulation of RNA-edited CaV1.3 channels. Cell Rep 5:367-377. CrossRef Medline
4. Bernard G, Shevell MI (2008) Channelopathies: a review. Pediatr Neurol 38:73-85. CrossRef Medline
5. 2+ channels. J Biol Chem 286:42736-42748. CrossRef Medline
6. Branch SY, Sharma R, Beckstead MJ (2014) Aging decreases L-type calcium channel currents and pacemaker firing fidelity in substantia nigra dopamine neurons. J Neurosci 34:9310-9318. CrossRef Medline
7. 2+ channels. Biochim Biophys Acta 1828:1530-1540. CrossRef Medline
8. Cameron DL, Wessendorf MW, Williams JT (1997) A subset of ventral tegmental area neurons is inhibited by dopamine, 5-hydroxytryptamine and opioids. Neuroscience 77:155-166. CrossRef Medline
9. Cano-Abad MF, Villarroya M, García AG, Gabilan NH, López MG (2001) Calcium entry through L-type calcium channels causes mitochondrial disruption and chromaffin cell death. J Biol Chem 276:39695-39704. CrossRef Medline
10. Chan CS, Guzman JN, Ilijic E, Mercer JN, Rick C, Tkatch T, Meredith GE, Surmeier DJ (2007) “Rejuvenation” protects neurons in mouse models of Parkinson’s disease. Nature 447:1081-1086. CrossRef Medline
11. Chien AJ, Carr KM, Shirokov RE, Rios E, Hosey MM (1996) Identification of palmitoylation sites within the L-type calcium channel beta2a subunit and effects on channel function. J Biol Chem 271:26465-26468. CrossRef Medline
12. Chung CY, Seo H, Sonntag KC, Brooks A, Lin L, Isacson O (2005) Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection. HumMol Genet 14:1709-1725. CrossRef Medline
13. Dragicevic E, Poetschke C, Duda J, Schlaudraff F, Lammel S, Schiemann J, Fauler M, Hetzel A, Watanabe M, Lujan R, Malenka RC, Striessnig J, Liss B (2014) Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons. Brain 137:2287-2302. CrossRef Medline
14. Dufour MA, Woodhouse A, Amendola J, Goaillard JM (2014a) Non-linear developmental trajectory of electrical phenotype in rat substantia nigra pars compacta dopaminergic neurons. Elife 2014:3. CrossRef Medline
15. Dufour MA, Woodhouse A, Goaillard JM (2014b) Somatodendritic ion channel expression in substantia nigra pars compacta dopaminergic neurons across postnatal development. J Neurosci Res 92:981-999. CrossRef Medline
16. Engel D, Jonas P (2005) Presynaptic action potential amplification by voltage-gated Na_ channels in hippocampal mossy fiber boutons. Neuron 45:405-417. CrossRef Medline
17. Evans RC, Khaliq ZM (2015) T-type calcium channels control non-linear dendritic integration in a vulnerable subpopulation of substantia nigra dopamine neurons. Soc Neurosci Abstr 801.03.
18. Fields HL, Hjelmstad GO, Margolis EB, Nicola SM (2007) Ventral tegmental area neurons in learned appetitive behavior and positive reinforcement. Annu Rev Neurosci 30:289-316. CrossRef Medline
19. Gentet LJ, Williams SR (2007) Dopamine gates action potential backpropagation in midbrain dopaminergic neurons. J Neurosci 27:1892-1901. CrossRef Medline
20. Goaillard JM, Taylor AL, Schulz DJ, Marder E (2009) Functional consequences of animal-to-animal variation in circuit parameters. Nat Neurosci 12:1424-1430. CrossRef Medline
21. Grimm J, Mueller A, Hefti F, Rosenthal A (2004) Molecular basis for catecholaminergic neuron diversity. Proc Natl Acad Sci U||S|A 101: 13891-13896. CrossRef Medline
22. Guzman JN, Sanchez-Padilla J, Wokosin D, Kondapalli J, Ilijic E, Schumacker PT, Surmeier DJ (2010) Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1. Nature 468:696-700. CrossRef Medline
23. Häusser M, Stuart G, Racca C, Sakmann B (1995) Axonal initiation and active dendritic propagation of action potentials in substantia nigra neurons. Neuron 15:637-647. CrossRef Medline
24. Hollerman JR, Grace AA (1990) The effects of dopamine-depleting brain lesions on the electrophysiological activity of rat substantia nigra dopamine neurons. Brain Res 533:203-212. CrossRef Medline
25. 2+-dependent inactivation. Neuron 73:304-316. CrossRef Medline
26. 2+/calmodulin-dependent protein kinase II. J Neurosci 30:5125-5135. CrossRef Medline
27. Johnson SW, Wu YN (2004) Multiple mechanisms underlie burst firing in rat midbrain dopamine neurons in vitro. Brain Res 1019:293-296. CrossRef Medline
28. Kammermeier PJ, Jones SW (1998) Facilitation of L-type calcium current in thalamic neurons. J Neurophysiol 79:410-417. Medline
29. Khaliq ZM, Bean BP (2010) Pacemaking in dopaminergic ventral tegmental area neurons: depolarizing drive from background and voltagedependent sodium conductances. J Neurosci 30:7401-7413. CrossRef Medline
30. Kimm T, Bean BP (2014) Inhibition of A-type potassium current by the peptide toxin SNX-482. J Neurosci 34:9182-9189. CrossRef Medline
31. Kimm T, Khaliq ZM, Bean BP (2015) Differential regulation of action potential shape and burst-frequency firing by BK and Kv2 channels in substantia nigra dopaminergic neurons. J Neurosci 35:16404-16417. CrossRef Medline
32. 2+ channels activating at negative voltages. J Biol Chem 276:22100-22106. CrossRef Medline
33. Lammel S, Hetzel A, Häckel O, Jones I, Liss B, Roeper J (2008) Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system. Neuron 57:760-773. CrossRef Medline
34. Liss B, Roeper J (2008) Individual dopamine midbrain neurons: functional diversity and flexibility in health and disease. Brain Res Rev 58:314-321. CrossRef Medline
35. Lorenzon NM, Foehring RC (1995) Characterization of pharmacologically identified voltage-gated calcium channel currents in acutely isolated rat neocortical neurons: II. Postnatal development. J Neurophysiol 73: 1443-1451. Medline
36. Magee JC (1999) Voltage-gated ion channels in dendrites. In: Dendrites (Stuart G, Spruston N, Hausser M, eds), pp 139-160. New York: Oxford University.
37. Margolis EB, Mitchell JM, Ishikawa J, Hjelmstad GO, Fields HL (2008) Midbrain dopamine neurons: projection target determines action potential duration and dopamine D2 receptor inhibition. J Neurosci 28:8908-8913. CrossRef Medline
38. Neuhoff H, Neu A, Liss B, Roeper J (2002) I(h) channels contribute to the different functional properties of identified dopaminergic subpopulations in the midbrain. J Neurosci 22:1290-1302. Medline
39. Nieoullon A (2002) Dopamine and the regulation of cognition and attention. Prog Neurobiol 67:53-83. CrossRef Medline
40. 2+ channels is dependent on a shank-binding domain. J Neurosci 25:1050-1062. CrossRef Medline
41. Poulin JF, Zou J, Drouin-Ouellet J, Kim KY, Cicchetti F, Awatramani RB (2014) Defining midbrain dopaminergic neuron diversity by single-cell gene expression profiling. Cell Rep 9:930-943.
42. Puopolo M, Bean BP, Raviola E (2005) Spontaneous activity of isolated dopaminergic periglomerular cells of the main olfactory bulb. J Neurophysiol 94:3618-3627. CrossRef Medline
43. Puopolo M, Raviola E, Bean BP (2007) Roles of subthreshold calcium current and sodium current in spontaneous firing of mouse midbrain dopamine neurons. J Neurosci 27:645-656. CrossRef Medline
44. Richards CD, Shiroyama T, Kitai ST (1997) Electrophysiological and immunocytochemical characterization of GABA and dopamine neurons in the substantia nigra of the rat. Neuroscience 80:545-557. CrossRef Medline
45. Schultz W (2007) Multiple dopamine functions at different time courses. Annu Rev Neurosci 30:259-288. CrossRef Medline
46. Scuvee-Moreau J, Liegeois JF, Massotte L, Seutin V (2002) Methyl-laudanosine: a new pharmacological tool to investigate the function of smallconductance Ca(2+)-activated K(+) channels. J Pharmacol Exp Ther 302:1176-1183. CrossRef Medline
47. + conductances in substantia nigra dopaminergic neurons. Brain Res 1173:27-35. CrossRef Medline
48. + channel functional properties between dopamine and GABA neurons of the rat substantia nigra. J Neurophysiol 103:3099-3114. CrossRef Medline
49. Shepard PD, Stump D (1999) Nifedipine blocks apamin-induced bursting activity in nigral dopamine-containing neurons. Brain Res 817:104-109. CrossRef Medline
50. Sigworth F (1980) The variance of sodium current fluctuations at the node of Ranvier J Physiol 307:97-129. CrossRef
51. Soldatov NM, Zühlke RD, Bouron A, Reuter H (1997) Molecular structures involved in L-type calcium channel inactivation. J Biol Chem 272:3560-3566. CrossRef Medline
52. Surmeier DJ (2007) Calcium, ageing, and neuronal vulnerability in Parkinson’s disease. Lancet Neurol 6:933-938. CrossRef Medline
53. Surmeier DJ, Guzman JN, Sanchez-Padilla J (2010) Calcium, cellular aging, and selective neuronal vulnerability in Parkinson’s disease. Cell Calcium 47:175-182. CrossRef Medline
54. Parkinson Study Group (2013) Phase II safety, tolerability, and dose selection study of isradipine as a potential disease-modifying intervention in early Parkinson’s disease (STEADY-PD). Mov Disord 28:1823-1831. CrossRef Medline
55. Wise RA (2004) Dopamine, learning and motivation. Nat Rev Neurosci 5:483-494. CrossRef Medline
56. Wolfart J, Roeper J (2002) Selective coupling of T-type calcium channels to SK potassium channels prevents intrinsic bursting in dopaminergic midbrain neurons. J Neurosci 22:3404-3413. Medline
57. Wolfart J, Neuhoff H, Franz O, Roeper J (2001) Differential expression of the small-conductance, calcium-activated potassium channel SK3 is critical for pacemaker control in dopaminergic midbrain neurons. J Neurosci 21:3443-3456.
58. Xu W, Lipscombe D (2001) Neuronal Ca(V)1.3alpha(1) L-type channels activate at relatively hyperpolarized membrane potentials and are incompletely inhibited by dihydropyridines. J Neurosci 21:5944-5951. Medline
59. 2+ channel by hydrogen peroxide in guinea pig ventricular myocytes. J Physiol Sci 63:419-426. CrossRef Medline
60. Yung WH, Häusser MA, Jack JJ (1991) Electrophysiology of dopaminergic and non-dopaminergic neurones of the guinea-pig substantia nigra pars compacta in vitro. J Physiol 436:643-667. CrossRef Medline